{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T09:52:08Z","timestamp":1718704328822},"reference-count":20,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2020]]},"DOI":"10.2152\/jmi.67.315","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T22:07:33Z","timestamp":1604527653000},"page":"315-320","source":"Crossref","is-referenced-by-count":1,"title":["Clinical characteristics associated with 1-year tolvaptan efficacy in autosomal dominant polycystic kidney disease with a wide range of kidney functions"],"prefix":"10.2152","volume":"67","author":[{"given":"Taichi","family":"Murakami","sequence":"first","affiliation":[{"name":"Department of Nephrology, Ehime Prefectural Central Hospital, Ehime, Japan"},{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayo","family":"Ueta","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kishi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Tamaki","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Miya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kawashima Hospital, Tokushima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisato","family":"Shima","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Tokushima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Tokushima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Tokushima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kawahara","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Tokushima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideharu","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Minakuchi","sequence":"additional","affiliation":[{"name":"Department of Kidney Disease, Kawashima Hospital, Tokushima Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Doi","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH, 2nd\u2005:\u2005Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nature medicine Nat Med 10\u2005:\u2005363-364, 2004","DOI":"10.1038\/nm1004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yamaguchi T, Nagao S, Kasahara M, Takahashi H, Grantham JJ\u2005:\u2005Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 30\u2005:\u2005703-709, 1997","DOI":"10.1016\/S0272-6386(97)90496-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hanaoka K, Guggino WB\u2005:\u2005cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 11\u2005:\u20051179-1187, 2000","DOI":"10.1681\/ASN.V1171179"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wang X, Gattone V, 2nd, Harris PC, Torres VE\u2005:\u2005Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol 16\u2005:\u2005846-851, 2005","DOI":"10.1681\/ASN.2004121090"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gattone VH, 2nd, Wang X, Harris PC, Torres VE\u2005:\u2005Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9\u2005:\u20051323-1326, 2003","DOI":"10.1038\/nm935"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wang X, Wu Y, Ward CJ, Harris PC, Torres VE\u2005:\u2005Vasopressin directly regulates cyst growth in polycystic kidney disease. J Am Soc Nephrol 19\u2005:\u2005102-108, 2008","DOI":"10.1681\/ASN.2007060688"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwies FS\u2005:\u2005Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367\u2005:\u20052407-2418, 2012","DOI":"10.1056\/NEJMoa1205511"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Muto S, Kawano H, Higashihara E, Narita I, Ubara Y, Matsuzaki T, Ouyang J, Torres VE, Horie S\u2005:\u2005The effect of tolvaptan on autosomal dominant polycystic kidney disease patients\u2005:\u2005a subgroup analysis of the Japanese patient subset from TEMPO 3\u2005:\u20054 trial. Clin Exp Nephrol 19\u2005:\u2005867-877, 2015","DOI":"10.1007\/s10157-015-1086-2"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O\u2005:\u2005Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease. N Engl J Med 377\u2005:\u20051930-1942, 2017","DOI":"10.1056\/NEJMoa1710030"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH\u2005:\u2005Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int 41\u2005:\u20051311-1319, 1992","DOI":"10.1038\/ki.1992.195"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, Jr., Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP\u2005:\u2005Volume progression in polycystic kidney disease. N Engl J Med 354\u2005:\u20052122-2130, 2006","DOI":"10.1056\/NEJMoa054341"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Meijer E, Gansevoort RT, de Jong PE, van der Wal AM, Leonhard WN, de Krey SR, van den Born J, Mulder GM, van Goor H, Struck J, de Heer E, Peters DJ\u2005:\u2005Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease\u2005:\u2005optimal timing and dosing of the drug. Nephrol Dial Transplant 26\u2005:\u20052445-2453, 2011","DOI":"10.1093\/ndt\/gfr069"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Norman J\u2005:\u2005Fibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD). Biochim Biophys Acta 1812\u2005:\u20051327-1336, 2011","DOI":"10.1016\/j.bbadis.2011.06.012"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Irazabal MV, Torres VE, Hogan MC, Glockner J, King BF, Ofstie TG, Krasa HB, Ouyang J, Czerwiec FS\u2005:\u2005Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease. Kidney Int 80\u2005:\u2005295-301, 2011","DOI":"10.1038\/ki.2011.119"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Boertien WE, Meijer E, de Jong PE, ter Horst GJ, Renken RJ, van der Jagt EJ, Kappert P, Ouyang J, Engels GE, van Oeveren W, Struck J, Czerwiec FS, Oberdhan D, Krasa HB, Gansevoort RT\u2005:\u2005Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function. Am J Kidney Dis 65\u2005:\u2005833-841, 2015","DOI":"10.1053\/j.ajkd.2014.11.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Rahbari-Oskoui F, Williams O, Chapman A\u2005:\u2005Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 29\u2005:\u20052194-2201, 2014","DOI":"10.1093\/ndt\/gft513"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ruiz-Ortega M, Egido J\u2005:\u2005Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int 52\u2005:\u20051497-1510, 1997","DOI":"10.1038\/ki.1997.480"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Wolf G, Neilson EG\u2005:\u2005Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am J Physiol 259\u2005:\u2005F768-777, 1990","DOI":"10.1152\/ajprenal.1990.259.5.F768"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB\u2005:\u2005Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med 371\u2005:\u20052255-2266, 2014","DOI":"10.1056\/NEJMoa1402685"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fick-Brosnahan GM, Belz MM, McFann KK, Johnson AM, Schrier RW\u2005:\u2005Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease\u2005:\u2005a longitudinal study. Am J Kidney Dis 39\u2005:\u20051127-1134, 2002","DOI":"10.1053\/ajkd.2002.33379"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/67\/3.4\/67_315\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:45:04Z","timestamp":1623113104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/67\/3.4\/67_315\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":20,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.67.315","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}